{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T17:22:16Z","timestamp":1775236936942,"version":"3.50.1"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P2O GM103424-20"],"award-info":[{"award-number":["P2O GM103424-20"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006952","name":"State of Louisiana Board of Regents","doi-asserted-by":"publisher","award":["LEQSF (2021\\u201324)-RD-A-35"],"award-info":[{"award-number":["LEQSF (2021\\u201324)-RD-A-35"]}],"id":[{"id":"10.13039\/100006952","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018524","name":"Kansas IDeA Network of Biomedical Research Excellence","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018524","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014517","name":"Louisiana Biomedical Research Network","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014517","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Computational Biology and Chemistry"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.compbiolchem.2025.108728","type":"journal-article","created":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T01:18:16Z","timestamp":1760145496000},"page":"108728","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"P2","title":["Discovery of pyrazole derivatives as promising leads against NSCLC: An integrated computational and experimental approach"],"prefix":"10.1016","volume":"120","author":[{"given":"Ali","family":"GholamianMoghaddam","sequence":"first","affiliation":[]},{"given":"Atchimnaidu","family":"Siriki","sequence":"additional","affiliation":[]},{"given":"Fahima","family":"Afroja","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1956-3079","authenticated-orcid":false,"given":"Siva","family":"Murru","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"issue":"15","key":"10.1016\/j.compbiolchem.2025.108728_bib1","doi-asserted-by":"crossref","first-page":"4599","DOI":"10.3390\/molecules26154599","article-title":"Betulin, a newly characterized compound in acacia auriculiformis bark, is a Multi-Target protein kinase inhibitor","volume":"26","author":"Ahmadu","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.compbiolchem.2025.108728_bib2","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s12013-017-0821-6","article-title":"Identification of phytochemicals targeting c-Met kinase domain using consensus docking and molecular dynamics simulation studies","volume":"76","author":"Aliebrahimi","year":"2018","journal-title":"Cell Biochem. Biophys."},{"key":"10.1016\/j.compbiolchem.2025.108728_bib3","doi-asserted-by":"crossref","first-page":"938","DOI":"10.3390\/molecules25040938","article-title":"Large-scale virtual screening against the MET kinase domain identifies a new putative inhibitor type","volume":"25","author":"Bresso","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.compbiolchem.2025.108728_bib4","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1111\/cbdd.14030","article-title":"1,3-diarylpyrazolones as potential anticancer agents for non-small cell lung cancer: synthesis and antiproliferative activity evaluation","volume":"99","author":"Dahal","year":"2022","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.compbiolchem.2025.108728_bib5","doi-asserted-by":"crossref","DOI":"10.1038\/srep42717","article-title":"SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules","volume":"7","author":"Daina","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.compbiolchem.2025.108728_bib6","doi-asserted-by":"crossref","first-page":"137","DOI":"10.18773\/austprescr.2014.050","article-title":"P-glycoprotein and its role in drug-drug interactions","volume":"37","author":"Finch","year":"2014","journal-title":"Aust. Prescr."},{"key":"10.1016\/j.compbiolchem.2025.108728_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsps.2024.102139","article-title":"High throughput virtual screening and validation of plant-based EGFR L858R kinase inhibitors against non-small cell lung cancer: an integrated approach utilizing GC-MS, network pharmacology, docking, and molecular dynamics","volume":"32","author":"Gao","year":"2024","journal-title":"Saudi Pharm. J."},{"key":"10.1016\/j.compbiolchem.2025.108728_bib8","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1093\/nar\/gku293","article-title":"Swisstargetprediction: a web server for target prediction of bioactive small molecules","volume":"42","author":"Gfeller","year":"2014","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.compbiolchem.2025.108728_bib9","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/nrc3563","article-title":"Role of ABL family kinases in cancer: from leukaemia to solid tumours","volume":"13","author":"Greuber","year":"2013","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.compbiolchem.2025.108728_bib10","doi-asserted-by":"crossref","first-page":"4835","DOI":"10.1021\/acs.jcim.4c00151","article-title":"Discovery of a novel and potent LCK inhibitor for leukemia treatment via deep learning and molecular docking","volume":"64","author":"Guo","year":"2024","journal-title":"J. Chem. Inf. Model"},{"key":"10.1016\/j.compbiolchem.2025.108728_bib11","doi-asserted-by":"crossref","first-page":"1200490","DOI":"10.3389\/fchem.2023.1200490","article-title":"Identifying promising GSK3\u03b2 inhibitors for cancer management: a computational pipeline combining virtual screening and molecular dynamics simulations","volume":"11","author":"Hua","year":"2023","journal-title":"Front. Chem."},{"key":"10.1016\/j.compbiolchem.2025.108728_bib12","doi-asserted-by":"crossref","first-page":"30621","DOI":"10.1074\/jbc.M604633200","article-title":"Identification of novel glycogen synthase kinase-3beta substrate-interacting residues suggests a common mechanism for substrate recognition","volume":"281","author":"Ilouz","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.compbiolchem.2025.108728_bib13","doi-asserted-by":"crossref","DOI":"10.1177\/1010428317701643","article-title":"Computational analysis of ABL kinase mutations allows predicting drug sensitivity against selective kinase inhibitors","volume":"39","author":"Kamasani","year":"2017","journal-title":"Tumour Biol."},{"key":"10.1016\/j.compbiolchem.2025.108728_bib14","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1158\/1078-0432.CCR-14-2791","article-title":"Therapeutic targeting of anaplastic lymphoma kinase in lung cancer: a paradigm for precision cancer Medicine","volume":"21","author":"Katayama","year":"2015","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.compbiolchem.2025.108728_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2019.101906","article-title":"Advances and challenges in precision medicine in salivary gland cancer","volume":"80","author":"Lassche","year":"2019","journal-title":"Cancer Treat. Rev."},{"issue":"1","key":"10.1016\/j.compbiolchem.2025.108728_bib16","doi-asserted-by":"crossref","first-page":"99","DOI":"10.3390\/biom14010099","article-title":"A review of CYP-mediated drug interactions: mechanisms and in vitro drug-drug interaction assessment","volume":"14","author":"Lee","year":"2024","journal-title":"Biomolecules"},{"issue":"7","key":"10.1016\/j.compbiolchem.2025.108728_bib17","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1021\/acsmedchemlett.5b00157","article-title":"Molecular property design: does everyone get it?","volume":"6","author":"Leeson","year":"2015","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.compbiolchem.2025.108728_bib18","doi-asserted-by":"crossref","first-page":"38","DOI":"10.3389\/fphar.2013.00038","article-title":"Lazar: a modular predictive toxicology framework","volume":"4","author":"Maunz","year":"2013","journal-title":"Front. Pharm."},{"key":"10.1016\/j.compbiolchem.2025.108728_bib19","doi-asserted-by":"crossref","first-page":"2881","DOI":"10.18632\/oncotarget.2037","article-title":"GSK-3 as potential target for therapeutic intervention in cancer","volume":"5","author":"McCubrey","year":"2014","journal-title":"Oncotarget"},{"key":"10.1016\/j.compbiolchem.2025.108728_bib20","doi-asserted-by":"crossref","first-page":"146","DOI":"10.2174\/157340911795677602","article-title":"Molecular docking: a powerful approach for structure-based drug discovery","volume":"7","author":"Meng","year":"2011","journal-title":"Curr. Comput. Aided Drug Des."},{"key":"10.1016\/j.compbiolchem.2025.108728_bib21","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1056\/NEJMoa0810699","article-title":"Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma","volume":"361","author":"Mok","year":"2009","journal-title":"N. Engl. J. Med."},{"issue":"46","key":"10.1016\/j.compbiolchem.2025.108728_bib22","doi-asserted-by":"crossref","first-page":"45842","DOI":"10.1021\/acsomega.4c04639","article-title":"Design and Optimization of Quinazoline Derivatives as Potent EGFR Inhibitors for Lung Cancer Treatment: A Comprehensive QSAR, ADMET, and Molecular Modeling Investigation","volume":"9","author":"Moussaoui","year":"2024","journal-title":"ACS Omega"},{"key":"10.1016\/j.compbiolchem.2025.108728_bib23","doi-asserted-by":"crossref","first-page":"85","DOI":"10.5114\/bta.2021.103765","article-title":"Molecular docking and prediction of ADME\/drug-likeness properties of potentially active antidiabetic compounds isolated from aqueous-methanol extracts of gymnema sylvestre and combretum micranthum","volume":"102","author":"Ononamadu","year":"2021","journal-title":"BioTechnologia (Pozn)"},{"key":"10.1016\/j.compbiolchem.2025.108728_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e20300","article-title":"Design, synthesis, anticancer activity and docking studies of novel quinazoline-based thiazole derivatives as EGFR kinase inhibitors","volume":"9","author":"Raghu","year":"2023","journal-title":"Heliyon"},{"key":"10.1016\/j.compbiolchem.2025.108728_bib25","doi-asserted-by":"crossref","first-page":"214","DOI":"10.3389\/fbioe.2019.00214","article-title":"Computational assessment of the pharmacological profiles of degradation products of chitosan","volume":"7","author":"Roman","year":"2019","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.compbiolchem.2025.108728_bib26","doi-asserted-by":"crossref","first-page":"889","DOI":"10.3389\/fphar.2017.00889","article-title":"vNN web server for ADMET predictions","volume":"8","author":"Schyman","year":"2017","journal-title":"Front Pharm."},{"key":"10.1016\/j.compbiolchem.2025.108728_bib27","doi-asserted-by":"crossref","first-page":"62","DOI":"10.3390\/cancers10030062","article-title":"Tumor resistance against ALK targeted therapy-where it comes from and where it goes","volume":"10","author":"Sharma","year":"2018","journal-title":"Cancers"},{"key":"10.1016\/j.compbiolchem.2025.108728_bib28","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1056\/NEJMoa1408440","article-title":"First-line crizotinib versus chemotherapy in ALK-positive lung cancer","volume":"371","author":"Solomon","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.compbiolchem.2025.108728_bib29","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1056\/NEJMoa1713137","article-title":"Osimertinib in untreated EGFR-mutated advanced non-small-cell lung cancer","volume":"378","author":"Soria","year":"2018","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.compbiolchem.2025.108728_bib30","first-page":"217","article-title":"Prognostic molecular assays on the rise for non-small cell lung cancer","volume":"4","author":"Sterlacci","year":"2012","journal-title":"J. Thorac. Dis."},{"key":"10.1016\/j.compbiolchem.2025.108728_bib31","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/clpt.2012.236","article-title":"Phenotypic vs. Target-based drug discovery for first-in-class medicines","volume":"93","author":"Swinney","year":"2013","journal-title":"Clin. Pharm. Ther."},{"key":"10.1016\/j.compbiolchem.2025.108728_bib32","doi-asserted-by":"crossref","first-page":"5790","DOI":"10.1158\/0008-5472.CAN-05-4187","article-title":"The structure of dasatinib (BMS-354825) bound to activated ABL kinase domain elucidates its inhibitory activity against imatinib-resistant ABL mutants","volume":"66","author":"Tokarski","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.compbiolchem.2025.108728_bib33","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1056\/NEJMoa2002787","article-title":"Capmatinib in MET exon 14-mutated or MET-amplified non-small-cell lung cancer","volume":"383","author":"Wolf","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.compbiolchem.2025.108728_bib34","doi-asserted-by":"crossref","first-page":"566058","DOI":"10.3389\/fphar.2020.566058","article-title":"Integrating machine learning-based virtual screening with multiple protein structures and bio-assay evaluation for discovery of novel GSK3\u03b2 inhibitors","volume":"11","author":"Zhu","year":"2020","journal-title":"Front. Pharmacol."}],"container-title":["Computational Biology and Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476927125003895?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476927125003895?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T22:46:35Z","timestamp":1773182795000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1476927125003895"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":34,"alternative-id":["S1476927125003895"],"URL":"https:\/\/doi.org\/10.1016\/j.compbiolchem.2025.108728","relation":{},"ISSN":["1476-9271"],"issn-type":[{"value":"1476-9271","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery of pyrazole derivatives as promising leads against NSCLC: An integrated computational and experimental approach","name":"articletitle","label":"Article Title"},{"value":"Computational Biology and Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.compbiolchem.2025.108728","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"108728"}}